Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Preclinical Research Services

Preclinical Research Services

Deeply integrate R&D experience, constantly climb the peak of R&D technology, and build an integrated innovation service platform for new drug R&D.

Preclinical Research Services

Medicilon is a Preclinical Research Outsourcing (CRO) company. With our more than 10 years experience on preclinical research services, we dedicated to provide our clients with customized preclinical services program in drug metabolism, pharmacokinetics, efficacy studies, and toxicology. We provide our clients a high-quality data and rapid turnaround time to support their drug development, preclinical studies and clinical research and to help them to select the most valuable drug candidates into clinical trials stage.

Medicilon's preclinical research services consist in three major parts: pharmacokinetics, disease transplantation models and drug safety evaluation. Our preclinical research services cover all of the aspects including design, in vivo studies, sample analysis, professional data analysis, IACUC review, and the preparation of application materials.

Download
Medicilon diamond icon.pngPreclinical Research Services
Medicilon diamond icon.pngPerfect and Complete Preclinical Research Laboratories
Medicilon diamond icon.pngCertification
Medicilon diamond icon.pngMedicilon’s Advantages
Service Cases

Medicilon Assists | China's First CD19×CD3×CD28 Trispecific Antibody Obtained FDA Implicit Approval.webp

Medicilon Assists | China's First CD19×CD3×CD28 Trispecific Antibody Obtained FDA Implicit Approval

Learn More

Medicilon Assistant| Jimincare's lgE Antibody Drug JYB1904 has been Approved for Clinical Trials.webp

Medicilon Assistant| Jimincare's lgE Antibody Drug JYB1904 has been Approved for Clinical Trials

Learn More

Sinovent's New Class 1 Anti-tumor Drug XNW14010 has been Approved for Clinical Trials.webp

Sinovent's New Class 1 Anti-tumor Drug XNW14010 has been Approved for Clinical Trials

Learn More

For more service cases, please contact us:

Inquire

Relevant laboratories
prev page next page
  • Whole-body-plethysmography-system
  • Oral-and-nasal-exposure-system
  • HEKA-Elektronik-EPC10-USB-DOUBLE
  • eppendorf-centrifuge-5810R
  • EMKA
  • DSI
  • thermo-scientific-Q-Exactive-HF-X(DAD)-Vanquish-Flex
  • SCIEX-Triple-Quad-5500
  • Q-Exactive-HF-X
  • pathological-diagnosis
  • Isotopic-analysis-equipment
  • HEKA-Elektronik-EPC10-USB-DOUBLE-details
  • Gyros
  • Covaris
Return